Last Posted: Jan 23, 2020
- Using Next generation Sequencing to Redefine BRCAness in Triple-Negative Breast Cancer.
Lin Po-Han et al. Cancer science 2020 Jan - Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.
Mavaddat Nasim et al. Breast cancer research : BCR 2020 Jan 22(1) 8 - BRCA Research Update: Looking Back At 2019 And Plans For The Future
S Domcheck Besser Center webinar, February 20, 2020 - The big reveal: Family disclosure patterns of BRCA genetic test results among young Black women with invasive breast cancer.
Conley Claire C et al. Journal of genetic counseling 2020 Jan - Comparison of clinical features and oncologic outcomes between familial (non-hereditary) and hereditary breast cancer in Korean female patients.
Park Chan Sub et al. Asian journal of surgery 2020 Jan - OSbrca: A Web Server for Breast Cancer Prognostic Biomarker Investigation With Massive Data From Tens of Cohorts.
Yan Zhongyi et al. Frontiers in oncology 2019 91349 - Impact of proactive high-throughput functional assay data on BRCA1 variant interpretation in 3684 patients with breast or ovarian cancer
HK Kim, J Hum Genetics, January 2020 - The Reinterpretation of Genetic Tests Is Rare
Wall Street Journal, January 11, 2020 - The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan.
Murakami Wakana et al. Breast cancer (Tokyo, Japan) 2019 Sep 26(5) 552-561 - Contralateral Breast Cancer and Ipsilateral Breast Tumor Recurrence in BRCA1/2 Carriers and Non-Carriers at High-Risk of Hereditary Breast Cancer.
Yoon Kyung-Hwak et al. Journal of breast cancer 2019 Dec 22(4) 587-598
No hay comentarios:
Publicar un comentario